Periconceptual dietary folic acid supplementation reduces the incidence of neural tube defects (NTDs).
Their use has been advocated by the Chief Medical Officer (CMO), the Consultant Advisor in Obstetrics & Gynaecology (O & G), the Senior Consultant in O & G British Forces in Germany (BFG) and by Medical Administration & Technical Instruction (MA & TI) in all NAAFI outlets.
An audit of awareness of the recommendations and use of such supplements amongst pregnant women in BFG was performed over a 12 week period in BMH Rinteln. 16.6% (5/6) and 17.6% (34/193) of those with and without a history of a pregnancy affected by a NTD respectively had taken the correct dose before conception.
Knowledge of and compliance with the recommendations is poor.
An opportunity to postively influence health in a « captive » population is being lost.
Mots-clés Pascal : Acide folique, Chimiothérapie, Voie orale, Fécondation, Gestation, Tube neural, Malformation, Spina bifida, Indication, Prévention, Evaluation, Homme, Femelle, Information thérapeutique, Royaume Uni, Europe, Système ostéoarticulaire pathologie, Rachis pathologie, Maladie congénitale
Mots-clés Pascal anglais : Folic acid, Chemotherapy, Oral administration, Fecundation, Pregnancy, Neural tube, Malformation, Spina bifida, Indication, Prevention, Evaluation, Human, Female, Therapeutic information, United Kingdom, Europe, Diseases of the osteoarticular system, Spine disease, Congenital disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0000589
Code Inist : 002B02N. Création : 21/05/1997.